Growth Factor Therapy for Tissue Repair in Houston, TX

What I’d check before adding growth factor therapy here

CDC PLACES (2023, crude) estimates 13.9% of adults in Houston have diagnosed diabetes — 1.9 points above the U.S. 12% figure. Census city-proper population is 2,304,580. If you are adding growth factor therapy, start with that epidemiology and with Novitas Solutions (JH) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.

Cash PRP and Medicare CTPs in the same hallway

• CDC PLACES (2023, crude) estimates 13.9% of adults in Houston have diagnosed diabetes — 1.9 points above the U.S. 12% figure. Adult arthritis here is 19.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Separate 361 tissue, PRP, and CTP tickets before you market growth factor therapy in Houston. Mixing lanes is how recoupments start.
• Undiagnosed diabetes is 27.6% of U.S. adults who have the disease (CDC). Wound and joint programs in Texas will see patients who were never labeled diabetic on the referral — screening and offloading still belong in the protocol.
• Texas DSHS publishes state chronic-disease context that clinics can cite in patient education. Pair that with FDA 361 labeling — homologous use, minimal manipulation — so marketing does not outrun the product's actual regulatory lane.

Uninsured mix and Medicare CTPs in the same building

America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Houston we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 13.9% of adults in Houston have diagnosed diabetes — 1.9 points above the U.S. 12% figure.

How we’d stand this up in clinic